中国全科医学

• •

随机对照试验中使用替代终点的扩展指南解读:基于SPIRIT和CONSORT标准

周慧1,唐欲博1,陈杰1,唐可京1,2,元刚3*,姚弥4,5*   

  1. 1.中山大学附属第一医院药学部;2.中山大学附属第一医院呼吸与危重症;3.中山大学附属第一医院老年医学科;4.北京大学第一医院全科医学科;5.北京大学医学部全科医学学系
  • 收稿日期:2025-03-19 接受日期:2025-04-18
  • 通讯作者: 姚弥

Interpretation for the reporting of surrogate endpoints in randomized controlled trial protocols: based on SPIRIT and CONSORT extension checklist

  • Received:2025-03-19 Accepted:2025-04-18
分享到

摘要: 随机对照试验正在越来越广泛地使用替代终点作为主要结局的评价指标,虽然其具有加快试验进程、减少样本量等诸多优势,但是,并非所有的替代终点都能很好的预测干预效果。因此,使用替代终点作为主要结局指标的规范性和后续验证问题受到人们的重视和思考。近期发布的《基于SPIRIT和CONSORT标准的替代终点扩展指南》对使用替代终点的随机对照试验制定了最低参照标准,旨在提高这些试验方案或报告的科学性及规范性。两个扩展指南的制定符合国际指南编写流程,这些条目在优化试验方案/报告质量的同时也有助于减少临床资源的浪费。本文将两个扩展指南一同对比解读,以期为广大研究者提供参考,引起相关从业者对替代终点及其背后诸多问题的关注。

关键词: 替代终点, 替代指标, 主要结局, 随机对照试验, 临床试验

Abstract: Surrogate endpoints are frequently used to substitute for target outcomes in randomized controlled trials to shorter trial duration, reduced sample size and etc. But some surrogate endpoints would increase uncertainty of the intervention’s true effect and unreliable in revealing intervention harms. We do need better reporting of trials that rely on surrogate endpoints. The SPIRIT-Surrogate and CONSORT- Surrogate provides the minimum reporting requirements for trials that use surrogate endpoints. Those extension checklists help to improve transparency, usefulness of trial findings, and ultimately reduce research waste. We interpreted these two guidelines with the aim of providing reference for practitioners and drawing their attention to surrogate endpoints.

Key words: Surrogate endpoints, Surrogate indicators, Primary outcomes, Randomized controlled trials, Clinical trials